Ashraf Badros
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma (NCT02289222) | Ashraf Badros | 2014-12-30 |
Track Ashraf Badros automatically
Every clearance here is in the API, with alerts when new ones post.